Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q63844056)
Watch
English
Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS)
clinical trial
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
clinical trial
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
urinary incontinence
0 references
country
Belgium
0 references
Canada
0 references
Czech Republic
0 references
France
0 references
Poland
0 references
Portugal
0 references
start time
June 2012
0 references
end time
April 2014
0 references
number of participants
144
0 references
clinical trial phase
phase III clinical trial
0 references
minimum age
18
year
0 references
study type
interventional study
0 references
Identifiers
ClinicalTrials.gov ID
NCT01600716
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit